Redemption of autoreactive B cells

Proceedings of the National Academy of Sciences of the United States of America

Volumn 111, Issue 25, 2014, Pages 9022-9023

  Haynes, Barton F ^a   Verkoczy, Laurent ^a   Kelsoe, Garnett ^a  

^a DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B CELL ANTIGEN RECEPTOR; CYTIDINE DEAMINASE; EPITOPE; LYMPHOCYTE ANTIGEN RECEPTOR; LYSOZYME; NEUTRALIZING ANTIBODY; UNCLASSIFIED DRUG;

ADAPTIVE IMMUNITY; APOPTOSIS; AUTOIMMUNITY; B LYMPHOCYTE; CELL PROLIFERATION; CELL SURVIVAL; COMPLEMENTARITY DETERMINING REGION; FOLLICULAR DENDRITIC CELL; GERMINAL CENTER; HEAVY CHAIN; HELPER CELL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMORAL IMMUNITY; IMMUNIZATION; IMMUNOLOGICAL TOLERANCE; MUTATION; NONHUMAN; NOTE; PATHOGENESIS; PRIORITY JOURNAL; PROGENY; T LYMPHOCYTE;

ANIMALS; AUTOANTIBODIES; B-LYMPHOCYTES; CLONAL ANERGY; FEMALE; GERMINAL CENTER; HUMANS; IMMUNOGLOBULIN VARIABLE REGION; MALE; SOMATIC HYPERMUTATION, IMMUNOGLOBULIN;

EID: 84903481474     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1407877111     Document Type: Note

References (32)

1. Goodnow CC, Sprent J, Fazekas de St Groth B, Vinuesa CG (2005) Cellular and genetic mechanisms of self tolerance and autoimmunity. Nature 435(7042):590-597. (Pubitemid 40825498)
2. Victora GD, Nussenzweig MC (2012) Germinal centers. Annu Rev Immunol 30:429-457.
3. Meffre E, Wardemann H (2008) B-cell tolerance checkpoints in health and autoimmunity. Curr Opin Immunol 20(6):632-638.
4. Menard L, Samuels J, Ng YS, Meffre E (2011) Inflammation-independent defective early B cell tolerance checkpoints in rheumatoid arthritis. Arthritis Rheum 63(5):1237-1245.
5. Bowes T, et al. (2002) Tolerance to self gangliosides is the major factor restricting the antibody response to lipopolysaccharide core oligosaccharides in Campylobacter jejuni strains associated with Guillain-Barré syndrome. Infect Immun 70(9):5008-5018.
6. Haynes BF, Verkoczy L (2014) Host controls of HIV neutralizing antibodies. Science 344(6184):588-589.
7. Yang G, et al. (2013) Identification of autoantigens recognized by the 2F5 and 4E10 broadly neutralizing HIV-1 antibodies. J Exp Med 210(2):241-256.
8. Alam SM, et al. (2009) Role of HIV membrane in neutralization by two broadly neutralizing antibodies. Proc Natl Acad Sci USA 106(48):20234-20239.
9. Mouquet H, Warncke M, Scheid JF, Seaman MS, Nussenzweig MC (2012) Enhanced HIV-1 neutralization by antibody heteroligation. Proc Natl Acad Sci USA 109(3):875-880.
10. Haynes BF, Kelsoe G, Harrison SC, Kepler TB (2012) B-cell - lineage immunogen design in vaccine development with HIV-1 as a case study. Nat Biotechnol 30(5):423-433.
11. Verkoczy L, et al. (2010) Autoreactivity in an HIV-1 broadly reactive neutralizing antibody variable region heavy chain induces immunologic tolerance. Proc Natl Acad Sci USA 107(1):181-186.
12. Verkoczy L, et al. (2013) Induction of HIV-1 broad neutralizing antibodies in 2F5 knock-in mice: Selection against membrane proximal external region-associated autoreactivity limits T-dependent responses. J Immunol 191(5):2538-2550.
13. Haynes BF, et al. (2005) Cardiolipin polyspecific autoreactivity in two broadly neutralizing HIV-1 antibodies. Science 308(5730):1906-1908. (Pubitemid 40941873)
14. Sabouri Z, et al. (2014) Redemption of autoantibodies on anergic B cells by variable-region glycosylation and mutation away from self-reactivity. Proc Natl Acad Sci USA 111:E2567-E2575.
15. Goodnow CC, et al. (1988) Altered immunoglobulin expression and functional silencing of self-reactive B lymphocytes in transgenic mice. Nature 334(6184):676-682.
16. Goodnow CC (1992) Transgenic mice and analysis of B-cell tolerance. Annu Rev Immunol 10:489-518.
17. Han S, Zheng B, Dal Porto J, Kelsoe G (1995) In situ studies of the primary immune response to (4-hydroxy-3-nitrophenyl)acetyl. IV. Affinity-dependent, antigen-driven B cell apoptosis in germinal centers as a mechanism for maintaining self-tolerance. J Exp Med 182(6):1635-1644.
18. Fugmann SD, Lee AI, Shockett PE, Villey IJ, Schatz DG (2000) The RAG proteins and V(D)J recombination: Complexes, ends, and transposition. Annu Rev Immunol 18:495-527. (Pubitemid 30365389)
19. Wardemann H, et al. (2003) Predominant autoantibody production by early human B cell precursors. Science 301(5638):1374-1377. (Pubitemid 37075812)
20. Jankovic M, Casellas R, Yannoutsos N, Wardemann H, Nussenzweig MC (2004) RAGs and regulation of autoantibodies. Annu Rev Immunol 22:485-501. (Pubitemid 38680431)
21. Wardemann H, Nussenzweig MC (2007) B-cell self-tolerance in humans. Adv Immunol 95:83-110. (Pubitemid 47381589)
22. Adams E, Basten A, Goodnow CC (1990) Intrinsic B-cell hyporesponsiveness accounts for self-tolerance in lysozyme/anti-lysozyme double-transgenic mice. Proc Natl Acad Sci USA 87(15):5687-5691.
23. Goodnow CC, Adelstein S, Basten A (1990) The need for central and peripheral tolerance in the B cell repertoire. Science 248(4961):1373-1379.
24. Merrell KT, et al. (2006) Identification of anergic B cells within a wild-type repertoire. Immunity 25(6):953-962. (Pubitemid 44894955)
25. Tiller T, et al. (2007) Autoreactivity in human IgG+ memory B cells. Immunity 26(2):205-213. (Pubitemid 46329436)
26. Mietzner B, et al. (2008) Autoreactive IgG memory antibodies in patients with systemic lupus erythematosus arise from nonreactive and polyreactive precursors. Proc Natl Acad Sci USA 105(28):9727-9732. (Pubitemid 352031368)
27. Shokat KM, Goodnow CC (1995) Antigen-induced B-cell death and elimination during germinal-centre immune responses. Nature 375(6529):334-338.
28. Richardson C, et al. (2013) Molecular basis of 9G4 B cell autoreactivity in human systemic lupus erythematosus. J Immunol 191(10):4926-4939.
29. Chan TD, et al. (2012) Elimination of germinal-center-derived self-reactive B cells is governed by the location and concentration of self-antigen. Immunity 37(5):893-904.
30. Schwickert TA, et al. (2011) A dynamic T cell-limited checkpoint regulates affinity-dependent B cell entry into the germinal center. J Exp Med 208(6):1243-1252.
31. Chen Y, et al. (2013) Common tolerance mechanisms, but distinct cross-reactivities associated with gp41 and lipids, limit production of HIV-1 broad neutralizing antibodies 2F5 and 4E10. J Immunol 191(3):1260-1275.
32. Verkoczy L, Diaz M (2014) Autoreactivity in HIV-1 broadly neutralizing antibodies: Implications for their function and induction by vaccination. Curr Opin HIV AIDS 9(3):224-234.